Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jian Zhu

Clinical trials sponsored by Jian Zhu, explained in plain language.

Not yet recruiting 1

Engineered immune cells take aim at stubborn autoimmune disease

Disease control Not yet recruiting

This early-phase study tests a new cell therapy called universal STAR-T cells in people with autoimmune diseases that cause dangerously low platelet counts. About 6 adults aged 18-65 will receive a single infusion of these engineered cells to see if they are safe and can help con…

Phase: PHASE1 • Sponsor: Jian Zhu • Aim: Disease control

Last updated May 22, 2026 13:52 UTC